Table 1 Baseline characteristics of enrolled patients with HCC
Variable | Value, n=44 (%) |
|---|---|
Age (year) | 57 ± 8.9 |
Sex male/female | 40 (90.9%)/4 (9.1%) |
BMI | 25.0 ± 3.3 |
Drinking no/yes | 15 (34.1%)/29 (65.9%) |
HBsAg negative/positive | 7 (15.9%)/37 (84.1%) |
HCV negative/positive | 39 (88.6%)/5 (11.4%) |
Time interval from radical (hepatectomy to advanced recurrence) ≤ 1 year/> 1 year | 24 (54.5%)/20 (45.5%) |
Liver cirrhosis no/yes | 10 (22.7%)/34 (77.3%) |
Number of intrahepatic lesions ≤ 3/>3 | 21 (47.7%)/23 (52.3%) |
PVTT classification | |
 No portal vein tumor thrombosis | 37 (84.1%) |
 VP2 | 1 (2.3%) |
 VP3 | 4 (9.1%) |
 VP4 | 2 (4.5%) |
Extrahepatic metastases | |
 No | 21 (47.7%) |
 Yes | 23 (52.3%) |
  Bone metastases | 5 (11.4%) |
  Lung metastases | 7 (15.9%) |
  Lymph node metastases | 3 (6.8%) |
  Abdominal metastases | 5 (11.4%) |
  Diaphragmatic metastases | 3 (6.8%) |
BCLC staging at recurrence B/C | 15 (34.1%)/29 (65.9%) |
Ascites no/yes | 42 (95.5%)/2 (4.5%) |
AFP (≤ 400 ng/mL) | 38 (86.4%) |
Child-Pugh classification A/B | 40 (90.9%)/4 (9.1%) |
ECOG performance 0/1 | 35 (79.5%)/9 (20.5%) |
ALT (U/L) | 32.1 ± 23.6 |
AST (U/L) | 36.6 ± 23.1 |
ALB (g/L) | 41.0 ± 5.8 |
Total bilirubin level (mg/dL) | 15.0 ± 6.9 |